Commercialization Activities. Each Party will have final decision-making authority over any matter relating to the Commercialization of the Licensed Compound and Licensed Products in its respective Territory, provided that such decision is exercised using each Party’s best scientific and medical judgment and in good faith with the focus on benefitting patients.
Appears in 4 contracts
Sources: Collaboration Agreement (Eikon Therapeutics, Inc.), Collaboration Agreement (Eikon Therapeutics, Inc.), Collaboration Agreement (Eikon Therapeutics, Inc.)